Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

25%

1 of 4 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A
2(66.7%)
Early Phase 1
1(33.3%)
3Total
N/A(2)
Early Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT03323723Not ApplicableCompleted

Disposable Stress Urinary Incontinence Pessary Device Study

Role: lead

NCT01585012Early Phase 1Completed

Usability Study of the Focus Touch™ Conception System: Semen Collection

Role: lead

NCT02038322Not ApplicableCompleted

The Stork OTC: Collection, Placement & Delivery

Role: lead

NCT01564940Completed

Human Factors Usability Study of Ib2C Conception System

Role: lead

All 4 trials loaded